Australian Children’s Cancer Trials (ACCT) is a subcommittee of the Australian and New Zealand Children’s Haematology and Oncology Group (ANZCHOG), the leading children’s cancer body in Australia. ACCT’s primary goal is to address the absence of treatment options involving new drug therapies for Australian children and adolescents where standard treatment has failed to treat their disease.
ACCT provides expertise in the design and implementation of Australian based laboratory research and clinical trials of new therapies for childhood and adolescent cancer. ACCT also provides access to international trials for children and adolescents through our relationships with international children’s cancer trial groups.
This co-operative group has been formed by the leadership of each of the children’s cancer departments of the major children’s hospitals in Australia.
ACCT members include:
Sydney Children’s Hospital
The Children’s Hospital at Westmead, Sydney
John Hunter Children’s Hospital, Newcastle
The Royal Children’s Hospital, Brisbane
The Royal Children’s Hospital, Melbourne
Princess Margaret Hospital for Children, Perth
Women and Children’s Hospital, Adelaide
Click here to read more about ACCT.